CELG

Celgene Corporation News Headlines

$90.83
*  
1.37
1.53%
Get CELG Alerts
*Delayed - data as of Sep. 16, 2014 9:54 ET  -  Find a broker to begin trading CELG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CELG Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Cramer's Mad Money - Angie's List For Self-Improvement (9/15/14)
9/16/2014 6:13:00 AM - Seeking Alpha

Jim Cramer Answers Twitter (TWTR) Questions on Alibaba IPO, Yahoo! (YHOO), Apple (AAPL) and More
9/15/2014 12:47:00 PM - TheStreet

Celgene Looks Unstoppable
9/15/2014 4:35:00 AM - Seeking Alpha

These 7 States Have the Highest Rates of Pancreatic Cancer
9/13/2014 12:17:03 PM - Motley Fool

Why Pure Luck Isn't Going To Work
9/11/2014 10:23:00 AM - Seeking Alpha

Why Celgene's Stock is up 11% in 2014
9/11/2014 8:45:02 AM - Motley Fool

Pluristem & United Therapeutics Progress with Phase I Study - Analyst Blog
9/9/2014 4:50:00 PM - Zacks.com

2 Years Of Dividend Growth Investing - 10 Lessons I Have Learned
9/9/2014 2:33:00 PM - Seeking Alpha

How Bad Is This News for Celgene Corporation?
9/9/2014 1:45:49 PM - Motley Fool

Celgene To Present At Morgan Stanley Conference; Webcast At 12:55 PM ET
9/9/2014 11:55:00 AM - RTT News

Celgene's Revlimid Impresses in Phase III NDMM Study - Analyst Blog
9/5/2014 4:45:00 PM - Zacks.com

#PreMarket Primer: Friday, September 5: US Labor Market Expected To Show Improvement
9/5/2014 6:54:00 AM - Benzinga

Alkermes Completes Enrolment for Phase II ALKS 3831 Study - Analyst Blog
9/4/2014 6:10:00 PM - Zacks.com

Celgene Corp To Present At Citi Biotech Conference; Webcast At 10:00 AM ET
9/4/2014 9:00:00 AM - RTT News

Celgene Publishes Data From Phase III FIRST Trial Of Revlimid - Qucik Facts
9/4/2014 7:58:00 AM - RTT News

Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead
9/3/2014 6:28:00 PM - Investor's Business Daily

Determining Celgene's Fair Value
9/3/2014 11:24:00 AM - Seeking Alpha

Is It Time to Buy Celgene Corporation's Stock?
9/3/2014 11:03:03 AM - Motley Fool

Bristol-Myers Returns Clazakizumab Rights, Alder Sinks - Analyst Blog
9/3/2014 11:02:00 AM - Zacks.com

Cramer's Mad Money - Fascinating Schisms (9/2/14)
9/3/2014 6:17:00 AM - Seeking Alpha

Bristol-Myers/Pfizer's Eliquis Encourages in VTE Analysis - Analyst Blog
9/2/2014 6:50:00 PM - Zacks.com

IBB, CELG, BIIB, ALXN: ETF Outflow Alert
9/2/2014 11:18:23 AM - BNK Invest

Biotechnology, Oil And Brazil ETFs To Watch This Week
9/2/2014 10:05:59 AM - Benzinga

Regeneron Pharmaceuticals' Pipeline Progress Raises Costs - Analyst Blog
8/29/2014 6:30:00 PM - Zacks.com

Today's Market: Red Hot Biotech And Big Pharma Names To Watch
8/29/2014 8:22:00 AM - Seeking Alpha